Five Prime Therapeutics, Inc. (Nasdaq: FPRX) announced today the pricing of an underwritten public offering of 3,410,000 shares of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE